Case Study: OcellO / SME / Search for Additional Partners in Japan

OcellO – from NL

OcellO B.V. was founded in 2011 in Leiden. It is a privately owned contract research organisation based on technology developed at Leiden University. 

Case Study: Protobios Ltd. / SME

Protobios – from EE    

Protobios Ltd. was founded in 2003. The company is developing new diagnostic tests and offering services in the field of immunology analysis. Since their founding the company has contributed to the development of novel technologies in field cell technology and immunology.

Case Study: HealthCapital: A German Cluster


HealthCapital Berlin-Brandenburg is the principal healthcare sector cluster of the German capital region. Its cluster management has dedicated structures for the coordination of the regional biotech and pharma industries.

30-04-15 to 30-04-15 | 10:30 h - 11:30h

Webinar 41: Cell technology, cell therapy, tissue engineering and gene therapy in Japan

What’s on in Japan regarding cell technology and gene therapy, and are there partnership opportunities?

Japan has managed to establish a highly coordinated national program for cell engineering, not only in R&D, but also for translational activities such as clinical trials, equipment manufacturing and standardization. Still, Japan, as always, is hungry for further innovations. Might it make sense to team up with a pragmatic leader?


BioJapan is Asia’s premier partnering event for the international biotechnology industry. This event facilitates interaction between biotech executives, R&D professionals, alliance management personnel and licensing professionals from Japan and overseas. The event is attended by almost all Japanese biotech and pharmaceutical companies. BioJapan also offers a partnering programme which allows attendees to set up meetings with one another prior to the event. The fair is held in October every year.


Subscribe to RSS - Biotechnology